EPCAM and neoplasm: In these patients staged as M0 (no metastasis), BR (biochemical PSA relapse), and M1 (established metastasis), EpCAM-positivity of bona fide tumour cells significantly increased with progression from M0 to BR, and further to M1 stages from 9 to 16–33%.